Folate levels and polymorphisms in the genes MTHFR, MTR, and TS in colorectal cancer

Clinical Medicine Insights: Oncology

Volumn 8, Issue , 2014, Pages 15-20

  Taflin, Helena ^a   Wettergren, Yvonne ^a   Odin, Elisabeth ^a   Carlsson, Göran ^a   Derwinger, Kristoffer ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Colorectal cancer; Folate levels; Gene polymorphisms

Indexed keywords

5 METHYLTETRAHYDROFOLIC ACID; 5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); GENOMIC DNA; METHIONINE SYNTHASE; METHYLENETETRAHYDROFOLIC ACID; TETRAHYDROFOLIC ACID; THYMIDYLATE SYNTHASE;

ADULT; AGED; ARTICLE; CANCER TISSUE; CARCINOGENESIS; COHORT ANALYSIS; COLON MUCOSA; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOME SIZE; GENOTYPE; HUMAN; HUMAN TISSUE; INDEL MUTATION; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MTHFR GENE; MTR GENE; REAL TIME POLYMERASE CHAIN REACTION; RECTUM MUCOSA; TANDEM REPEAT; TISSUE DISTRIBUTION; TISSUE LEVEL; TS GENE;

EID: 84896711408     PISSN: 11795549     EISSN: 11795549     Source Type: Journal    
DOI: 10.4137/CMO.S12701     Document Type: Article

References (22)

1. Flynn A, Hirvonen T, Mensink GB, et al. Intake of selected nutrients from foods, from fortification and from supplements in various European countries. Food Nutr Res. 2009;53.
2. Niculescu MD, Zeisel SH. Diet, methyl donors and DNA methylation: interactions between dietary folate, methionine and choline. J Nutr. 2002;132(8 Suppl):2333S-5S.
3. Blount BC, Mack MM, Wehr CM, et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci U S A. 1997;94(7):3290-5.
4. Ren DN, Kim IY, Koh SB, et al. Comparative analysis of thymidylate synthase at the protein, mRNA, and DNA levels as prognostic markers in colorectal adenocarcinoma. J Surg Oncol. 2009;100(7):546-52.
5. Sharp L, Little J. Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: a HuGE review. Am J Epidemiol. 2004;159(5):423-43.
6. Jennings BA, Kwok CS, Willis G, Matthews V, Wawruch P, Loke YK. Functional polymorphisms of folate metabolism and response to chemotherapy for colorectal cancer, a systematic review and meta-analysis. Pharmacogenet Genomics. 2012;22(4):290-304.
7. Odin E, Wettergren Y, Carlsson G, et al. Expression and clinical significance of methylenetetrahydrofolate reductase in patients with colorectal cancer. Clin Colorectal Cancer. 2006;5(5):344-9.
8. Barbosa PR, Stabler SP, Machado AL, et al. Association between decreased vitamin levels and MTHFR, MTR and MTRR gene polymorphisms as determinants for elevated total homocysteine concentrations in pregnant women. Eur J Clin Nutr. 2008;62(8):1010-21.
9. Odin E, Wettergren Y, Carlsson G, Gustavsson B. Determination of reduced folates in tumor and adjacent mucosa of colorectal cancer patients using LC-MS/MS. Biomed Chromatogr. 2013;27(4):487-95.
10. Goodwin RA, Asmis TR. Overview of systemic therapy for colorectal cancer. Clin Colon Rectal Surg. 2009;22(4):251-6.
11. Toxicity of fluorouracil in patients with advanced colorectal cancer: effect of administration schedule and prognostic factors. Meta-Analysis Group In Cancer. J Clin Oncol. 1998;16(11):3537-41.
12. Afzal S, Gusella M, Vainer B, et al. Combinations of polymorphisms in genes involved in the 5-Fluorouracil metabolism pathway are associated with gastrointestinal toxicity in chemotherapy-treated colorectal cancer patients. Clin Cancer Res. 2011;17(11):3822-9.
13. Thomas F, Motsinger-Reif AA, Hoskins JM, et al. Methylenetetrahydrofolate reductase genetic polymorphisms and toxicity to 5-FU-based chemoradiation in rectal cancer. Br J Cancer. 2011;105(11):1654-62.
14. Taflin H, Wettergren Y, Odin E, Carlsson G, Derwinger K. Gene polymorphisms MTHFRC677T and MTRA2756G as predictive factors in adjuvant chemotherapy for stage III colorectal cancer. Anticancer Res. 2011;31(9):3057-62.
15. Fernández-Peralta AM, Daimiel L, Nejda N, Iglesias D, Medina Arana V, González-Aguilera JJ. Association of polymorphisms MTHFR C677T and A1298C with risk of colorectal cancer, genetic and epigenetic characteristic of tumors, and response to chemotherapy. Int J Colorectal Dis. 2010;25(2):141-51.
16. Allegra C. Thymidylate synthase levels: prognostic, predictive, or both? J Clin Oncol. 2002;20(7):1711-3.
17. Lecomte T, Ferraz JM, Zinzindohoué F, et al. Thymidylate synthase gene polymorphism predicts toxicity in colorectal cancer patients receiving 5-fluorouracil-based chemotherapy. Clin Cancer Res. 2004;10(17):5880-8.
18. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10(1):111-3.
19. Sohn KJ, Croxford R, Yates Z, Lucock M, Kim YI. Effect of the methylenetetrahydrofolate reductase C677T polymorphism on chemosensitivity of colon and breast cancer cells to 5-fluorouracil and methotrexate. J Natl Cancer Inst. 2004;96(2):134-44.
20. Shia J, Klimstra D, Nitzkorski, et al. Immunohistochemical expression of folate receptor alfa in colorectal carcinoma: patterns and biological significance. Human Pathology. 2008;39:498-505.
21. Yu K, Wang W, Ding Y, et al. Polymorphism of thymidylate synthase gene associated with its protein expression in human colon cancer. World Journal of Gastroenterology. 2008;28;14(4):617-21.
22. Tejpar S, Bertagnolli M, Bosman F, et al. Prognostic and predictive biomarkers in resected colon cancer: current status and future perspectives for integrating genomics into biomarker discovery. Oncologist. 2010;15(4):390-404.